It also reveals FST as a key factor involved in prostate cancer‐stroma interaction in vitro and in vivo, suggesting that the role of FST should be revisited in the context of different stages and mutational profiles of prostate cancer, which may provide insights from a precision oncology perspective and identify potential strategies for disease management. The gene discussed is FST; the disease is prostate carcinoma.